Our Business Areas.


The Neurology business unit is focused on treatments for stroke, traumatic brain injury, vascular dementia, Alzheimer’s disease, and Parkinson’s disease. We aim to continuously develop safer and easier to use products in this field and our portfolio encompasses proprietary delivery devices such as pens and pumps, as well as drug products.

For example, for patients with advanced Parkinson’s disease, we offer Apomorphine for intermittent off episodes in the form of a single injection pen/cartridge or as a continuous infusion using a mini pump.


The Specialties business is focused on the development, production and commercialization of complex and value-added injectable formulations that support compliance, convenience and safety for the patients and healthcare professionals. Our R&D team is extensively engaged in the development of a broad portfolio of products in oncology, intensive care and hormone therapeutics.


We offer our customers a wide range of services: from development through commercial contract manufacturing. Leveraging decades of experience and global know-how, we produce high-quality sterile products in vials, prefilled syringes, cartridges and ampoules as well as implants for third-party customers at our site in Jena. In addition, we provide a comprehensive full service for the manufacturing, testing and supporting dossier development of sterile dosage forms. Our separate manufacturing area for the filling of sterile hormones rounds off our extensive range of services.

For more information, please contact: newbusiness@everpharma.com


In addition to our internal development pipeline, we are also seeking to broaden our portfolio through in-licensing, acquisitions, and partnerships.

For more information, please contact: newbusiness@everpharma.com